|
|||||
|
|
Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance |
|
| Affiliation: | 2. Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY 10021;4. Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, CA 92093 |
| Abstract: | |
| Keywords: | phosphoinositide insulin signaling insulin resistance phosphoinositides lipid kinases receptor tyrosine kinases signal transduction targeted therapies |
| 本文献已被 ScienceDirect 等数据库收录！ | |